Scienture gets Nasdaq $1.00 bid notice; 180-day cure period
Scienture Holdings (SCNX) disclosed it received a Nasdaq notice that its common stock failed to meet the $1.00 minimum bid price for 30 consecutive business days, triggering a compliance period.
Rhea-AI Filing Summary
Scienture Holdings (SCNX) disclosed it received a Nasdaq notice that its common stock failed to meet the $1.00 minimum bid price for 30 consecutive business days, triggering a compliance period. The company has 180 calendar days, until April 13, 2026, to regain compliance by maintaining a closing bid at or above $1.00 for at least ten consecutive business days.
The notice has no immediate effect on the listing or trading of the stock on Nasdaq. Scienture believes it can regain compliance, while noting there is no assurance it will meet the requirement or other Nasdaq criteria.
Positive
- None.
Negative
- None.
Insights
Nasdaq bid-price deficiency with a defined 180-day cure window.
SCNX has been below the $1.00 bid threshold for 30 consecutive business days, triggering a standard Nasdaq compliance process. The company now has 180 calendar days—until April 13, 2026—to post a closing bid at or above $1.00 for ten straight trading days.
The notice explicitly carries no immediate listing or trading impact. Outcomes depend on future trading levels or corporate actions the company may pursue, if any. If the minimum is met for ten consecutive days within the window, compliance is restored; otherwise, additional Nasdaq procedures may follow per exchange rules.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Scienture Holdings (SCNX) announce regarding Nasdaq listing compliance?
How long does SCNX have to regain compliance with Nasdaq’s bid price rule?
What is required for SCNX to regain Nasdaq bid price compliance?
Does the Nasdaq notice immediately affect SCNX’s trading status?
Did SCNX comment on its ability to regain compliance?
AI-generated analysis. How Rhea-AI works. Not financial advice.